Skip to content

Surgical Treatment of High Perianal Fistulas

Ligation of Intersphincteric Fistula Tract (LIFT) Versus Rectal Advanced Mucosal Flap (RAF) in Surgical Treatment of High Perianal Fistulas

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01997645
Acronym
LIFTRAF
Enrollment
140
Registered
2013-11-28
Start date
2013-11-30
Completion date
Unknown
Last updated
2013-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Fistula, Rectal Fistula

Keywords

Anal fistula, Rectal fistula, Intersphincteric fistula, Perianal fistula

Brief summary

Perianal fistula is a chronic phase of anorectal infection that occurs predominantly in the third and fourth decade of life. According to Parks classification fistulas have been divided into intersphincteric, transsphincteric, suprasphincteric and extrasphincteric. Simple fistulotomy can be performed with satisfactory outcomes in low fistula tracts but in high (transsphincteric) fistulas it may affect anal continence seriously. Therefore sphincter preserving procedures should be preferred in these cases. Rectal advancement mucosal flap (RAF) is one of the methods used in surgical fistula eradication with high success rate in cryptoglandular fistulas. However, this technique is technically demanding and results can be expert depended with wide spread of healing rates (24-100%) in individual studies as referred in recent systematic review. Ligation of the intersphincteric fistula tract (LIFT) has been presented in 2007 as a simple sphincter preserving technique. The success rate varies between 40-95% with low overall incontinence rate (6%). The aim of the study is to compare the efficacy of the LIFT and RAF procedure for treatment of high perianal fistulas.

Interventions

PROCEDURELIFT
PROCEDURERAF

Sponsors

University Hospital Hradec Kralove
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years old or older * Diagnosis of simple intersphincteric or transsphincteric fistula * Patients able to comply with the study protocol as per investigator criteria * Signed and dated informed consent by the patient * Absence of any

Design outcomes

Primary

MeasureTime frameDescription
Recurrence rateOne yearFistula recurrence will be defined according to AGA (American Gastroenterological Association) criteria as a purulent secretion from external fistula opening followed the compression. Fistula recurrence will be confirmed by evaluation under anesthesia (followed by drainage).

Secondary

MeasureTime frameDescription
Postoperative pain14 daysPostoperative pain will be assessed 4 times per day during the first 2 postoperative days (VAS - visual analogue scale), after that 3 times per day over next 14 days (patient's diary).
Pre- and postoperative continenceOne yearPre- and postoperative continence will be evaluated with Wexner score.
Postoperative morbidityOne monthWill be evaluated according to Clavien-Dindo classification.
Quality of lifeOne yearFor quality of life evaluation SF-36 questionnaire will be used.

Countries

Czechia

Contacts

Primary ContactJúlius Örhalmi, MD
orhalmi@volny.cz+420606506391

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026